Skip to content
Vial Announces Dosing of First Patient in Phase 1 Healthy Volunteer Trial
ABOUT US
ABOUT US
CAREERS
CONTACT US
PIPELINE
INHBE siRNA
IL-13 x TSLP
TMPRSS6
MYOSTATIN (GDF8)
α4β7 x IL-23
IL‑31 x IL‑4Rα
UPDATES
PARTNERSHIP
LICENSING
Articles
Updates
Search
Search
All Resources
Press Releases
Videos
All Resources
Press Releases
Videos
Articles
Vial is geared up to attend the 44th Annual J.P. Morgan Healthcare Conference in San Francisco
Articles
Vial is geared up to attend the 44th Annual J.P. Morgan Healthcare Conference in San Francisco
Clear search querie
